Agenus Inc. – Filings and Transcripts

NASDAQ: AGEN
Share price (5/28/26): $3.40
Market cap (5/28/26): $142 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 03/31/26 Q1

ended 12/31/25 FY 2025

ended 09/30/25 Q3

ended 06/30/25 Q2

ended 03/31/25 Q1

Prospectuses and Registrations Filter

Automatic shelf registration

Registration of securities for employees

Shelf registration

Prospectus supplement for primary offering

Registration of securities for employees

Ownership Filter

News Filter

Change in Directors, Officers or Compensation

Reports First Quarter 2026 Financial Results and Highlights BOT+BAL Execution Across Global Access and Phase 3 Development

Reports 2025 Results; BOT+BAL Advances to Phase 3 and Early Access Programs Expand Globally With Initial Revenues Recognized

Announces Closing of $141M Strategic Collaboration With Zydus Lifesciences to Advance BOT+BAL and Strengthen U.S. Manufacturing Readiness

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Preliminary proxy

Other Filter

Scanned paper annual report submission

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC

Scanned paper annual report submission